Welcome to our dedicated page for AMERIPRISE FINANCIAL SEC filings (Ticker: AMP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMERIPRISE FINANCIAL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMERIPRISE FINANCIAL's regulatory disclosures and financial reporting.
Ameriprise Financial executive Walter S. Berman, Executive VP and CFO, reported a stock sale. On February 5, 2026, he sold 7,000 shares of Ameriprise Financial common stock at a weighted average price of $544.2159 per share, in multiple trades with prices ranging from $543.98 to $544.645.
After the sale, he beneficially owned 5,609 shares of Ameriprise common stock directly. He also had an estimated 363.83 shares credited to his account through the Ameriprise Financial Stock Fund in the company’s 401(k) plan as of February 5, 2026, which uses unit accounting.
Ameriprise Financial’s chairman and CEO, James M. Cracchiolo, reported a series of open-market sales of Ameriprise common stock on February 4, 2026. The transactions covered multiple blocks of shares, including 7,136 shares at a weighted average price of $540.1052 and 15,696 shares at $548.6051, with several additional sales between those price levels.
After these sales, Cracchiolo directly held 107,633 shares of Ameriprise common stock. The filing also notes an estimated 1,724.844 shares held indirectly through his account in the Ameriprise Financial Stock Fund under the company’s 401(k) plan as of February 4, 2026.
Ameriprise Financial director Liane J. Pelletier received a pro rata annual equity grant in the form of 182.3555 phantom stock (annual) units on February 3, 2026, valued at $530.05 per unit.
Each phantom stock unit represents the right to receive one share of Ameriprise common stock. The units will be settled in Ameriprise common shares on a one-for-one basis in a lump sum after the quarter following the end of her service as a non-employee director.
Ameriprise Financial director Christopher J. Williams reported a routine compensation-related award of derivative securities. On 02/03/2026, he acquired 38.9114 shares of Phantom Stock (Retainer Deferral) at $530.05 per unit, bringing his total to 3,818.6956 phantom stock units held directly.
Each phantom stock unit represents the right to receive one share of Ameriprise Financial common stock, with distributions made according to participant elections under the Ameriprise Financial Deferred Share Plan for Outside Directors.
Ameriprise Financial EVP and General Counsel Heather J. Melloh reported two transactions in Ameriprise Financial common stock. On January 27, 2026, she acquired 999 shares at $0 per share in a transaction coded "A". The same day, she disposed of 306 shares in a transaction coded "F" at $498.33 per share. After these moves, she directly owned 3,684 shares of Ameriprise Financial common stock.
An Ameriprise Financial insider filed a Rule 144 notice to sell 7,000 shares of Ameriprise common stock through American Enterprise Investment Services on the NYSE, with an aggregate market value of 3,809,511.
The shares were acquired on 02/05/2025 via vesting of compensatory equity awards from Ameriprise Financial, Inc. The notice lists 92,905,713 common shares outstanding and targets an approximate sale date of 02/05/2026. The filer represents they are not aware of undisclosed material adverse information about Ameriprise’s current or prospective operations.
Ameriprise Financial common stockholder has filed a notice of proposed sale of 48,813 shares of common stock through American Enterprise Investment Services, Inc. on the NYSE, with an aggregate market value of 26,601,189 and an approximate sale date of 02/04/2026.
The 48,813 shares were acquired on 02/04/2025 through the vesting of compensatory equity awards from Ameriprise Financial, Inc. Shares of common stock outstanding were 92,905,713 at the time referenced in the notice.
Ameriprise Financial executive Walter S. Berman, Executive VP and CFO, reported routine equity compensation and related share activity. On January 31, 2026, 423 shares of Ameriprise common stock were withheld at $527.19 per share (code F), leaving him with 9,819 directly held shares.
On February 2, 2026, he acquired 2,790 shares of common stock at $0 per share (code A), increasing his direct holdings to 12,609 shares. He also received an employee stock option grant for 9,117 options with a $532.18 exercise price, covering 9,117 shares of common stock. According to the vesting schedule, one-third of these options vest after one year, one-third after two years, and the remainder three years from February 2, 2026. In addition, he has an estimated 363.95 shares indirectly through the Ameriprise Financial 401(k) plan.
Ameriprise Financial executive Joseph E. Sweeney, President – Products & Services, reported routine equity transactions in company stock. On January 31, 2026, he disposed of 235 shares of common stock at $527.19 per share, leaving 9,756 shares owned directly.
On February 2, 2026, he acquired 1,702 shares of common stock at a stated price of $0, increasing his direct common stock holdings to 11,458 shares. He also holds approximately 296.33 shares indirectly through the Ameriprise Financial 401(k) plan, based on unit accounting as of that date.
In addition, Sweeney received 5,561 employee stock options with an exercise price of $532.18 per share, expiring on February 3, 2036. According to the vesting terms, one-third of these options vest after one year, one-third after two years, and the remainder three years from February 2, 2026.
Ameriprise Financial executive Alvero Gumer, President–Insurance & Annuities, reported several equity transactions in Ameriprise Financial Inc. common stock and options. On January 31, 2026, he disposed of 32 shares of common stock at $527.19 per share, leaving 5,531 shares directly held.
On February 2, 2026, he acquired 405 shares of common stock at $0, increasing his direct common stock holdings to 5,936 shares. He also received an employee stock option grant for 1,326 options with a conversion price of $532.18 per share, vesting in three annual tranches from February 2, 2026 to February 2, 2029, and expiring on February 3, 2036. In addition, an estimated 1,064.63 shares are held indirectly in his Ameriprise Financial 401(k) plan account as of February 2, 2026.